The idyllic lifestyle of residents along the Emory and Tennessee rivers was changed forever Dec. 22, when more than 1 billion pounds of toxic coal ash sludge flooded more than 300 acres. The coal ash, a waste by-product from the Kingston Fossil Plant, a TVA energy production facility, burst through a retention pond retaining wall at the site and devastated the surrounding land and waterways.

A short documentary on the injustice of preemption.

There is an effort currently underway to remove the rights of consumers to seek justice through the court system when they are injured by a product or drug. The issue is preemption, and it would essentially provide companies with immunity from lawsuits despite negligent action on their part. Beasley Allen's Founding Shareholder, Jere L. Beasley, addresses this critical issue.

Beasley Allen Managing Shareholder Tom Methvin talks to Carolyn Hutcheson at Alabama Public Radio (WTSU) about the Alabama State Bar's Mortgage Foreclosure Assistance Program. Information on program available at the Bar web site, at www.alabar.org.

Beasley Allen law firm reached a settlement agreement on behalf of a Lee High School student who was killed when her school bus plunged 30 feet from an overpass.

Beasley Allen is representing the City of Montgomery and its Police Department in an effort to recover money spent for new law enforcement video equipment that failed to function properly.

Tom discusses the new mortgage foreclosure assistance from the Alabama State Bar Association.

Ted Meadows, lead pain pump attorney, discusses the issues surrounding the use of intra-articular post-operative pain pumps.  Pain pumps that dispense medicine directly to the join space can cause permanent cartilage damage, which can lead to joint replacement surgery, shoulder fusion, and amputation in extreme circumstances.

Trasylol, manufactered by Bayer Pharmaceuticals, has been used for more than twenty years to help reduce bleeding during surgery. Trasylol was permanently recalled in May 2008. Estimates are that over 1,000 people died each month from the use of Trasylol.

Vytorin is a prescription drug marketed by Merck and Shering-Plough for treating high cholesterol.  Vytorin has recently come under incredible scrutiny as new information shows that the drug is ineffective, incredibly expensive and may actually cause cancer.